Table 1.
Demographic, anthropometric, and clinical data of the participants.
| Characteristic | Individuals post-COVID-19 (n = 15) | Individuals with COPD (n = 15) | Individuals with IPF (n = 15) | Individuals with CHF (n = 15) | Individuals with stroke (n = 15) |
|---|---|---|---|---|---|
| Sex | 8 M / 7 F | 7 M/ 8 F | 6 M/ 9 F | 8 M/ 7 F | 9 M/ 6 F |
| Age (years) | 55 (12) | 69 (8) | 59 (9) | 51 (9) | 57 (11) |
| Body mass index (kg/m2) | 29.0 (4.9) | 25.3 (4.9) | 28.6 (3.5) | 26.4 (4.3) | 27.2 (2.9) |
| FEV1 (L) | 2.5 (0.5) | 1.3 (0.5) | 1.9 (0.7) | 3.3 (0.8) | 2.9 (0.6) |
| FEV1 (% predicted) | 81 (18) | 55 (24) | 72 (22) | 98 (17) | 89 (7) |
| FVC (L) | 3.2 (0.7) | 2.4 (0.8) | 2.4 (0.9) | 3.8 (0.9) | 3.4 (0.6) |
| FVC (% predicted) | 82 (20) | 75 (20 | 70 (20 | 97 (15) | 88 (8) |
| FEV1/FVC | 80 (7) | 55 (15) | 83 (7) | 86 (7) | 84 (9) |
| LVEF (%) | – | – | – | 36.5 (7.7) | – |
Data shown as mean (SD) except where otherwise indicated. M, Male; F, Female; COVID-19, Coronavirus disease 2019; COPD, Chronic obstructive pulmonary disease; IPF, Idiopathic pulmonary fibrosis; CHF, Chronic heart failure; FEV1, Forced expiratory volume in first second; FVC, Forced vital capacity; FEV1/FVC, Ratio of FEV1 to FVC; LVEF, Left ventricular ejection fraction.